Roche entered an agreement with Ibex Medical Analytics, which is engaged in artificial intelligence AI-based cancer diagnostics. Under the agreement, the companies will jointly develop an embedded image analysis workflow for pathologists to access Ibex’s AI algorithms, insights, and decision support tools using NAVIFY Digital Pathology, the cloud version of Roche’s uPath enterprise software.
Collaborations with AI companies like Ibex are made possible through Roche’s Digital Pathology Open Environment, which allows pathologists to securely access third-party AI-powered technology alongside Roche’s menu of AI-based image analysis tools. Read more.
